Background illustration for clinical trials search

Paid Clinical Trials Akron

Discover 1,423 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Safety and Tolerability Study of Jaktinib

for
Myelofibrosis
Location: Canton OH
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Sex: All

Age: 18+

Code: NCT05279001

Phase1, Recruiting

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: Canton OH, Detroit MI, Dayton OH, Cincinnati OH,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05914116

Phase1, Phase2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Canton OH, Cleveland OH, Toledo OH, Dearborn MI,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Canton OH, Hamilton, Buffalo NY, Grand Rapids MI,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

for
Major Depressive Disorder (MDD),
Location: North Canton OH, Independence OH, Allentown PA,
Sponsor: Seaport Therapeutics

Sex: All

Age: 18 - 65

Code: NCT07065240

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

ALTO-100 in Bipolar Disorder With Depression (BD-D)

for
Bipolar Disorder I or II With a Major Depressive Episode
Location: North Canton OH, Westlake OH, Gaithersburg MD,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70

Code: NCT06656416

Phase2, Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: North Canton OH, Massillon OH, Canton OH, Orrville OH,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase3, Recruiting

Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC

for
Chemotherapy-induced Nausea and Vomiting
Location: Massillon OH, Gettysburg PA, Bethesda MD, Skokie IL,
Sponsor: Xiamen LP Pharmaceutical Co., Ltd

Sex: All

Age: 18+

Code: NCT05199818

Phase3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Massillon OH, Canton OH, Zanesville OH, Maumee OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

for
Breast Cancer, Lung Cancer, Multiple Myeloma, Ovarian Cancer,
Location: Massillon OH, Canton OH, Cleveland OH, Evanston IL
Sponsor: Carevive Systems, Inc.

Sex: All

Age: 18+

Code: NCT05974150

Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Massillon OH, Cleveland OH, Pittsburgh PA, Columbus OH,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

for
Metastatic Renal Cell Carcinoma,
Location: Ravenna OH, Parma OH, Beachwood OH, Cleveland OH,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05327686

Phase2, Recruiting

A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near and Intermediate Vision in Pseudophakic Presbyopic Subjects

for
Presbyopia, Pseudophakia
Location: Brecksville OH, Bowie MD, Stillwater MN, Bloomington MN,
Sponsor: ReVision Optics, Inc.

Sex: All

Age: 50+

Code: NCT02668523

Phase3, Recruiting

Safety and Effectiveness of the PXL-Platinum 330 System

for
Corneal Ectasia, Keratoconus,
Location: Brecksville OH, Littleton CO
Sponsor: Colorado Eye Consultants/Cornea Consultants of Colorado

Sex: All

Age: 8+

Code: NCT04401865

Phase1, Phase2, Recruiting

Clareon TruPlus Study

for
Aphakia, Astigmatism
Location: Brecksville OH, Mt. Pleasant SC, Sugar Land TX,
Sponsor: Alcon Research

Sex: All

Age: 22+

Code: NCT07502456

Recruiting

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

for
Idiopathic Hypersomnia
Location: Canton OH, Cleveland OH, Lansing MI, Cincinnati OH,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06843590

Phase2, Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Canton OH, Farmington Hills MI, Flint MI, Florence KY,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06727604

Phase2, Recruiting

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

for
Gastrointestinal Stromal Neoplasms
Location: Canton OH, Knoxville TN, Toronto, Omaha NE
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07585266

Phase3, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

for
Neoplasms, Colorectal, Neoplasms
Location: Canton OH, Detroit MI, Hamilton, Nashville TN, Toronto,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07213609

Phase1, Phase2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Canton OH, Pittsburgh PA, Columbus OH, Ann Arbor MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase3, Recruiting